SOX2-mediated tumor heterogeneity and novel therapeutic strategies targeting cancer stem cells/relevance of tumor heterogeneity for development of strategies to inhibit peritoneal carcinomatosis.
Team
Sponsor
NORTE2020
Dates and Lifetime
From: 2016-05-01 To: 2019-12-31
Duration: 44 months
Reference
NORTE-01-0145-FEDER-000029
Code
CANCERL2WP3/4